Raymond and Beverly Sackler Convergence Symposium


We are proud to announce the first annual Tufts Cancer Symposium:

Precision Medicine: New Paths to Cancer Therapies through Convergent Research

View Photos from Symposium →

October 27, 2016

A leader in convergent research, Tufts University School of Medicine is bringing together top minds in cancer research and other scientific disciplines to foster a culture of cooperation and innovation among researchers across discipline boundaries, sharing their thinking and illuminating new paths to effective cancer therapies.


The robust program consists of lectures and panel discussions that focus on concepts and applications of precision medicine and how multidisciplinary, convergent research can provide us with innovative approaches to expedite the discovery and implementation of new custom-tailored cancer therapies.

This year’s symposium will have two sessions with a keynote address each and lunch sessions.

The morning session will focus on “Convergent Research”, which leverages collaborations among research groups that span diverse academic fields including biomedical, physical, mathematical and engineering sciences, to achieve transformative scientific innovation.

Dr. Charlotte Kuperwasser, Director of the Raymond and Beverly Sackler Convergence Laboratory at Tufts University School of Medicine will deliver the keynote address for the first session and introduce the Raymond and Beverly Sackler Convergence Laboratory. Dr. Philip Hinds, Professor and Chair of the Department of Developmental, Molecular and Chemical Biology at Tufts University School of Medicine will moderate.

Other confirmed speakers in this session include Dr. David Kaplan, Professor and Chair, Department of Biomedical Engineering, Dr. Joshua Kritzer, Associate Professor, Pearson Chemistry Laboratory, and Department of Chemistry, and Dr. William R. Sellers, Vice President and Global Head of Oncology, Novartis Institutes for BioMedical Research.

See Full Details →